Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

<p><strong>Introduction:</strong><br /> Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Most such biomarker studies ar...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Shi, L, Westwood, S, Baird, A, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, N, Morgan, A, Bos, I, Vos, S, Buckley, N, Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, E, Sleegers, K, Frisoni, G, Blin, O, Richardson, J, Bordet, R, Molinuevo, J, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, B, Streffer, J, Visser, P, Bertram, L, Lovestone, S, Nevado-Holgado, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2019

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Benzer Materyaller